Roth Spots

Excerpt

White-centered retinal hemorrhages, also known as Roth spots, were first described by Moritz Roth, a Swiss physician, in 1872. The eponym was introduced in 1878 by Moritz Litten, who reported that white-centered retinal hemorrhages were present in approximately 80% of cases of subacute bacterial endocarditis (SBE). Roth spots are most frequently associated with infective endocarditis but may also occur in hematologic, vascular, metabolic, and obstetric conditions such as leukemia, anemia, hypertensive retinopathy, preeclampsia, diabetic retinopathy, and anoxia.

Roth spots comprise distinctive retinal lesions characterized by pale or white centers within areas of hemorrhage. These lesions are often identified incidentally during fundus examination. Historically considered pathognomonic for SBE, Roth spots are now recognized as nonspecific indicators of systemic vascular injury. The classical retinal finding consists of a retinal hemorrhage secondary to ruptured capillaries, with the central pale region containing fibrin-platelet aggregates, ischemic necrosis, or leukocyte collections. These lesions usually localize in the posterior pole near the vascular arcades and may appear round or flame-shaped, depending on the retinal layer affected. Recognition of Roth spots is clinically significant, as their presence may serve as an early ophthalmic marker of underlying systemic disease.

The historical origins of Roth spots date to the 19th century, when Moritz Roth first described these lesions in association with septicemia. Subsequent refinements by Moritz Litten and later investigators clarified their histopathologic composition, disproving the early assumption that the white center represented bacterial microabscesses. Modern histologic and clinical evidence demonstrates that the pale center consists primarily of fibrin and platelet aggregates, occasionally interspersed with inflammatory cells, reflecting localized capillary rupture and thrombosis. This reinterpretation expanded the clinical relevance of Roth spots beyond endocarditis, establishing them as retinal manifestations of microvascular injury arising from diverse systemic disorders.

Roth spots develop when retinal capillaries sustain endothelial disruption, resulting in extravasation of red blood cells into surrounding retinal tissue. Platelet activation and fibrin deposition at the site of vascular injury generate the characteristic white center. Multiple mechanisms may precipitate this process, including septic embolization, immune complex deposition, hypoxia, and increased vascular fragility.

In infective endocarditis, circulating immune complexes and septic emboli lodge within retinal arterioles, initiating localized vasculitis and hemorrhage. In hematologic disorders such as leukemia and anemia, reduced oxygen delivery and altered blood viscosity impair vascular integrity. Metabolic and vascular diseases, including diabetes mellitus and hypertension, promote chronic microangiopathy. Collectively, these mechanisms illustrate that Roth spots represent a final common pathway of retinal microvascular injury resulting from systemic disease.

Clinically, Roth spots appear as round or oval retinal hemorrhages with a central pale area, typically located along the posterior pole or near the major vascular arcades. On ophthalmoscopy, superficial lesions often assume a flame-shaped configuration, whereas deeper hemorrhages appear round. Advances in multimodal retinal imaging, including spectral-domain optical coherence tomography (OCT) and fundus fluorescein angiography (FFA), have enhanced the understanding of their morphology. OCT reveals hyperreflective foci within the inner retinal layers corresponding to fibrin deposits, while FFA demonstrates hypofluorescence caused by blocked fluorescence and, in some cases, adjacent capillary nonperfusion.

The spectrum of systemic diseases associated with Roth spots is broad. SBE is the classic cause, where these lesions signify systemic embolization and immune-mediated vasculitis. Hematologic disorders such as leukemia, anemia, and thrombocytopenia feature Roth spots secondary to vascular fragility and coagulopathic abnormalities. In chronic metabolic and vascular diseases, including diabetes mellitus and hypertension, Roth spots may coexist with other microvascular changes such as cotton-wool spots and microaneurysms, both markers of focal retinal ischemia.

Autoimmune diseases, notably systemic lupus erythematosus (SLE) and antiphospholipid antibody syndrome (APLS), produce similar findings through immune-complex vasculopathy. Less commonly, Roth spots are associated with HIV retinopathy, meningococcal infection, septicemia, trauma, and Valsalva maneuvers.

From a diagnostic perspective, the identification of Roth spots necessitates a comprehensive systemic evaluation rather than isolated ophthalmic management (see Image. Management Pathway for Roth Spots). Baseline investigations should include a complete blood count (CBC), erythrocyte sedimentation rate, C-reactive protein, and blood cultures when infection is suspected. Echocardiography is warranted if SBE is a consideration, particularly in the presence of systemic manifestations such as fever, cardiac murmurs, or embolic events.

Hematologic assessment, including peripheral smear and bone marrow examination, may reveal anemia, leukemia, or thrombocytopenia. In metabolic or autoimmune disorders, evaluation should include fasting glucose, renal function tests, and serologic markers such as antinuclear antibody, anti-double-stranded DNA, antineutrophil cytoplasmic antibody (ANCA), and antiphospholipid antibodies. Therefore, the presence of Roth spots functions as a clinical biomarker prompting coordinated evaluation among ophthalmologists, internists, and cardiologists.

Roth spots are typically asymptomatic and seldom impair vision, yet their systemic significance is considerable. In SBE, the occurrence of these ocular lesions reflects embolic dissemination and correlates with disease severity. In hematologic disorders, the presence of Roth spots may parallel disease activity or recurrence, rendering serial fundus examinations a useful adjunct for systemic monitoring. The lesions generally resolve following treatment of the underlying condition, although recurrence may signify persistent vascular injury or inadequate systemic control.

Advances in retinal imaging technology have substantially improved the detection and interpretation of Roth spots. OCT and OCT angiography (OCTA) have delineated their structural and vascular features, revealing inner retinal hyperreflectivity and localized perfusion deficits. Adaptive optics and confocal imaging further enhance cellular-level visualization, allowing detailed characterization of the lesions. Recent developments in artificial intelligence (AI) have enabled automated detection of Roth spots and other hemorrhagic retinal signs, supporting integration of ocular imaging into systemic health assessment through teleophthalmology.

Although historically linked to diseases such as endocarditis, Roth spots remain clinically relevant in modern medicine. These lesions exemplify the interconnection between systemic vascular integrity and retinal microcirculation. The recognition of these retinal abnormalities should prompt consideration of systemic pathology, as they may indicate underlying processes with life-threatening potential. Awareness of the nonspecific nature of Roth spots prevents diagnostic overinterpretation while emphasizing their function as sentinel indicators of microvascular injury.

Roth spots represent a distinctive interface between ophthalmology and systemic medicine. The presence of these retinal hemorrhages reflects microvascular compromise due to infection, hematologic imbalance, autoimmune inflammation, or metabolic stress. Advances in imaging and the renewed focus on systemic retinal markers have reinforced their diagnostic value. While not pathognomonic for any single condition, Roth spots are critical clinical indicators guiding comprehensive systemic evaluation. For the modern clinician, identifying a Roth spot extends beyond ophthalmic observation, as it signifies the need to explore deeper systemic disease, underscoring the principle that the eye mirrors overall health.